SCHEMBL17366608

SCHEMBL17366608

Brc1c2ccc(-c3c4ccccc4c(-c4ccc5c(Br)c6cc(-c7ccccc7)ccc6c(Br)c5c4)c4ccccc34)cc2c(Br)c2ccc(-c3ccccc3)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
MAPK1 P28482 2/20 0.41
GRIN2D O15399 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41
KDM4E B2RXH2 2/20 0.37
MAPT P10636 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ESR1 P03372 2/20 0.37
ESR2 Q92731 2/20 0.37
ALOX5 P09917 2/20 0.36
JAK2 O60674 2/20 0.36
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35
DHFR P00374 1/20 0.35
MAP4K4 O95819 1/20 0.35
PLA2G2A P14555 1/20 0.35
PLA2G4A P47712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21517233 0.96 ALDH1A1 (0.41) ALDH1A1MAPK1GRIN2DGRIN2AGRIN2B
SCHEMBL17125452 0.96 ALDH1A1 (0.41) ALDH1A1MAPK1GRIN2DGRIN2AGRIN2B
SCHEMBL26086587 0.92 ALDH1A1 (0.41) ALDH1A1MAPK1GRIN2DGRIN2AGRIN2B
SCHEMBL276393 0.92 ALDH1A1 (0.41) ALDH1A1MAPK1GRIN2DGRIN2AGRIN2B
SCHEMBL25625159 0.92 ALDH1A1 (0.41) ALDH1A1MAPK1GRIN2DGRIN2AGRIN2B
SCHEMBL30307751 0.92 ALDH1A1 (0.41) ALDH1A1MAPK1GRIN2DGRIN2AGRIN2B
SCHEMBL19283273 0.92 ALDH1A1 (0.41) ALDH1A1MAPK1GRIN2DGRIN2AGRIN2B
SCHEMBL2017149 0.92 ALDH1A1 (0.48) ALDH1A1MAPK1GRIN2DGRIN2AGRIN2B
SCHEMBL26384351 0.90 ALDH1A1 (0.43) ALDH1A1MAPK1GRIN2DGRIN2AGRIN2B
SCHEMBL2082935 0.90 MAPK1 (0.43) ALDH1A1MAPK1GRIN2DGRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150376085-A1 ANTHRACENE COMPOUND, METHOD FOR PREPARING THE SAME, USE THEREOF AND ORGANIC LIGHT EMITTING DEVICE BOE TECHNOLOGY GROUP CO., LTD. (CN) 2015-12-31 US disclosed
US-20150376085-A1 ANTHRACENE COMPOUND, METHOD FOR PREPARING THE SAME, USE THEREOF AND ORGANIC LIGHT EMITTING DEVICE BOE TECHNOLOGY GROUP CO., LTD. (CN) 2015-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150376085-A1 ANTHRACENE COMPOUND, METHOD FOR PREPARING THE SAME, USE THEREOF AND ORGANIC LIGHT EMITTING DEVICE CYP2C9, AHR, AOC2 ALDH1A1 94/4885MAPK1 3054/4885GRIN2D 4669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.